235 related articles for article (PubMed ID: 9010649)
1. A practical guide to the use of interferons in the management of hepatitis virus infections.
Saracco G; Rizzetto M
Drugs; 1997 Jan; 53(1):74-85. PubMed ID: 9010649
[TBL] [Abstract][Full Text] [Related]
2. [Interferons as therapy in viral hepatitis: are promises kept?].
Spengler U
Ther Umsch; 1995 Oct; 52(10):645-51. PubMed ID: 7482375
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
4. Therapy of acute and chronic viral hepatitis.
Hoofnagle JH
Adv Intern Med; 1994; 39():241-75. PubMed ID: 8140956
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis D.
Niro GA; Rosina F; Rizzetto M
J Viral Hepat; 2005 Jan; 12(1):2-9. PubMed ID: 15655042
[TBL] [Abstract][Full Text] [Related]
7. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Myers RP; Poynard T
Cochrane Database Syst Rev; 2002; (4):CD003617. PubMed ID: 12519606
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski JP
Hepatology; 1996 Oct; 24(4):778-89. PubMed ID: 8855176
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic viral hepatitis.
Marcellin P; Benhamou JP
Baillieres Clin Gastroenterol; 1994 Jun; 8(2):233-53. PubMed ID: 7949457
[TBL] [Abstract][Full Text] [Related]
12. [Interferon treatment of chronic viral hepatitis].
Pirovino M
Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
[TBL] [Abstract][Full Text] [Related]
13. Current therapeutic trends in therapy for chronic viral hepatitis.
Liaw YF
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S346-53. PubMed ID: 9407357
[TBL] [Abstract][Full Text] [Related]
14. [Interferon therapy of chronic viral hepatitis in Hungary: 5-year experience. A multicenter study].
Pár A; Telegdy L; Gógl A; Müller E
Orv Hetil; 1999 May; 140(22):1227-33. PubMed ID: 10377733
[TBL] [Abstract][Full Text] [Related]
15. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
Brillanti S; Miglioli M; Barbara L
J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288
[TBL] [Abstract][Full Text] [Related]
16. Therapy for chronic viral hepatitis.
Alvarez F
Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
18. Therapy of viral hepatitis.
Hoofnagle JH
Digestion; 1998 Aug; 59(5):563-78. PubMed ID: 9705540
[TBL] [Abstract][Full Text] [Related]
19. Therapy of hepatitis C: overview.
Lindsay KL
Hepatology; 1997 Sep; 26(3 Suppl 1):71S-77S. PubMed ID: 9305668
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
